Searched for
PHARMACEUTICAL COMPLIANCE
Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests actionMaharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...- Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31xSymbiotec Pharmalab's IPO saw strong investor demand, closing oversubscribed 71.26 times. The company aimed to raise Rs 1,757 crore through...
- Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...
- Before Xi Jinping's likely India visit, Chinese money is pouring inIndia is cautiously reopening economic channels with China as Chinese linked investment returns after years of restrictions following the G...
- USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- India gets nearly Rs 5,000 crore FDI after easing rules for Chinese-linked firmsNew foreign investment rules are yielding positive results for India's economy. Twenty-nine investment proposals totaling over Rs 4,895 cro...
- Strikes in the Gulf changing rules behind India’s big-money betsIndia Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...
- Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health SciencesPharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...
- Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDAAurobindo Pharma announced its subsidiary Eugia Pharma received a USFDA warning letter. This follows an inspection of their Telangana formu...
- 'You are using sword to kill mosquito': Bombay HC tells Tukaram Mundhe-led FDA to use power judiciouslyThe Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged...
- Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...
- Maharashtra FDA cracks down on Ayurvedic drug makers, cancels 10 licencesMaharashtra FDA has launched a statewide crackdown on Ayurvedic drug manufacturers. Inspections revealed serious violations of manufacturin...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisionsNew rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has am...
- India's big billion-dollar trade deals are done. Now comes the real testIndia has spent years negotiating free trade agreements with some of the world's biggest economies. But signing the deals was only half the...
- Saudi Aramco supplier HD Fire plans to launch IPO in OctoberFire protection systems manufacturer HD Fire Protect is planning to launch its IPO in October through an offer for sale of 2.6 crore shares...
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...
Load More
